NEW YORK, March 9 (GenomeWeb News) - Nuvelo has completed its common stock offering, resulting in approximately $74.8 million in gross proceeds, the company said yesterday.

 

Nuvelo sold 5.75 million shares in total, including 5 million shares from its public offering and 750,000 shares offered to underwriters as an option.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.